Semaglutide for Alcohol Use Disorder (AUD)

Semaglutide for Alcohol Use Disorder (AUD) in Connecticut

VIRTUAL CONSULTATIONS FROM THE PRIVACY OF YOUR HOME ALSO AVAILABLE

Now Offered at Dr. Henry Sobo’s Office in Stamford, CT
Semaglutide for (AUD)

Are you or a loved one struggling with Alcohol Use Disorder (AUD)? A groundbreaking new approach may offer the relief you’ve been searching for. Dr. Henry Sobo is now offering Semaglutide therapy as a cutting-edge, science-backed option for individuals who want to reduce alcohol cravings and regain control over their lives.

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist originally developed for the treatment of diabetes and obesity. Under brand names like Wegovy and Ozempic, it has been widely prescribed to help reduce appetite and support weight loss. But recent research reveals it may also reduce cravings for alcohol — offering a powerful new treatment option for individuals with AUD.

Why Consider Semaglutide for Alcohol Use Disorder?

While traditional AUD treatments like naltrexone and disulfiram (Antabuse) have been available for decades, they are often limited in effectiveness and underutilized due to side effects and low patient adherence.

Semaglutide may offer a better-tolerated, dual-action solution:

Reduces alcohol cravings by targeting the brain’s reward system
Improves overall health, including blood sugar regulation and weight management
Early studies show fewer hospitalizations among patients using semaglutide for AUD

Clinical Research Backing Its Use

Multiple clinical and observational studies, including those published in the Journal of the American Medical Association, suggest that semaglutide significantly reduces:

Weekly alcohol consumption
Urges or cravings for alcohol
Associated risk factors like smoking and poor metabolic health

As reported in a major Swedish study of over 230,000 individuals with AUD, patients using GLP-1 medications like semaglutide were significantly less likely to be hospitalized for alcohol-related issues.

Who May Benefit from This Treatment?

Semaglutide for AUD may be appropriate for:

Adults who struggle with regular or binge drinking
Individuals who’ve tried traditional treatments without success
Patients seeking a non-judgmental, science-based approach to addiction
Those who may also benefit from weight management or metabolic improvement

Please Note: You do not need to be overweight or diabetic to qualify for this therapy. Dr. Sobo provides personalized evaluations to determine if this treatment is right for you.

What to Expect

Initial Consultation: Dr. Sobo will assess your medical history, lifestyle, and goals.
Personalized Plan: If appropriate, semaglutide will be prescribed and monitored under medical supervision.
Ongoing Support: We offer regular check-ins, counseling resources, and guidance throughout your treatment.

Take the First Step Toward Recovery

If you’re looking for an alternative to traditional AUD medications — or have never found a treatment that truly worked — Semaglutide may be the solution.

To schedule a consultation with Dr. Henry Sobo and learn more about this promising new treatment:

Call us at (203) 348-8805
Located in Stamford, CT
Contact Us

Reviewed and Approved by Dr. Henry Sobo, M.D.
Functional and Integrative Medicine Specialist – Stamford, CT
Over 30 years of experience helping patients find natural, science-driven solutions to chronic conditions and addiction.

Semaglutide for AUD

FAQs

What is Semaglutide, and how might it help with Alcohol Use Disorder (AUD)?

Semaglutide is a medication originally developed to treat type 2 diabetes and obesity. It mimics a hormone called GLP-1 that helps regulate appetite and blood sugar. Recent studies suggest Semaglutide may also reduce alcohol cravings and consumption by affecting reward pathways in the brain, potentially making it a promising treatment option for AUD.

Is Semaglutide currently approved for treating Alcohol Use Disorder?

No, Semaglutide is not yet FDA-approved specifically for treating Alcohol Use Disorder. However, clinical trials and early research are underway to explore its effectiveness in this area. Until it’s officially approved, any use of Semaglutide for AUD would be considered off-label and should only be done under the supervision of a qualified healthcare provider.

What are the potential benefits of using Semaglutide for people with AUD?

Early findings suggest that Semaglutide may help reduce the urge to drink, lower the amount of alcohol consumed, and support long-term behavior change. Its effects on appetite and cravings may translate into fewer binge drinking episodes and improved overall self-control, which are critical factors in AUD recovery.

Are there any risks or side effects associated with using Semaglutide for AUD?

Yes, like any medication, Semaglutide has potential side effects. Common ones include nausea, vomiting, constipation, and stomach pain. Rare but serious side effects include pancreatitis and kidney problems. Because its use for AUD is still being researched, more studies are needed to fully understand the risks in this context.

Who might be a good candidate for Semaglutide as part of AUD treatment?

Individuals who struggle with alcohol cravings and have not responded well to traditional AUD treatments may benefit from Semaglutide, especially if they also have obesity or metabolic issues. However, it’s crucial to consult a healthcare provider to evaluate personal health history, current medications, and suitability for off-label use.